#tirzepatide

[ follow ]
#weight-loss

A New Wave of Anti-Obesity Drugs Is on the Way

Tirzepatide's dual receptor activation may contribute to its efficacy in weight loss, while GIP's role is not fully understood yet.

Mounjaro Appears to Be Extremely Effective at Preventing Diabetes

Tirzepatide may reduce diabetes risk by 94% and help in weight loss for high-risk individuals.

Eli Lilly Offering Way Cheaper Zepbound, If You're Willing to Buy Your Own Syringes

Zepbound's new self-dosing option provides significant cost savings for patients willing to administer their own injections.

Weight loss drug could ease sleep apnoea in people with obesity, study says

Tirzepatide, a drug for diabetes and weight loss, could potentially be the first pharmaceutical treatment for obstructive sleep apnoea (OSA) in people with obesity.

How does weight loss drug Mounjaro work and why is it in such high demand?

Mounjaro, a leading weight loss drug, will be rolled out on the NHS prioritizing patients with significant health needs over 12 years.

The First Sleep Apnea Drug Is Here

Zepbound gains FDA approval for treating obstructive sleep apnea, marking a breakthrough in weight-loss medication benefits.

A New Wave of Anti-Obesity Drugs Is on the Way

Tirzepatide's dual receptor activation may contribute to its efficacy in weight loss, while GIP's role is not fully understood yet.

Mounjaro Appears to Be Extremely Effective at Preventing Diabetes

Tirzepatide may reduce diabetes risk by 94% and help in weight loss for high-risk individuals.

Eli Lilly Offering Way Cheaper Zepbound, If You're Willing to Buy Your Own Syringes

Zepbound's new self-dosing option provides significant cost savings for patients willing to administer their own injections.

Weight loss drug could ease sleep apnoea in people with obesity, study says

Tirzepatide, a drug for diabetes and weight loss, could potentially be the first pharmaceutical treatment for obstructive sleep apnoea (OSA) in people with obesity.

How does weight loss drug Mounjaro work and why is it in such high demand?

Mounjaro, a leading weight loss drug, will be rolled out on the NHS prioritizing patients with significant health needs over 12 years.

The First Sleep Apnea Drug Is Here

Zepbound gains FDA approval for treating obstructive sleep apnea, marking a breakthrough in weight-loss medication benefits.
moreweight-loss
#obesity-treatment

Mounjaro, the 'King Kong' of weight loss jabs, will be available in Ireland early next year

Mounjaro is an effective treatment option for obesity and type 2 diabetes, approved for use with diet and physical activity.

Which Weight Loss Drug Should You Choose (if You Get to Choose)?

People with obesity now have a choice between semaglutide and tirzepatide for weight loss, but deciding which to take is complex.

Mounjaro, the 'King Kong' of weight loss jabs, will be available in Ireland early next year

Mounjaro is an effective treatment option for obesity and type 2 diabetes, approved for use with diet and physical activity.

Which Weight Loss Drug Should You Choose (if You Get to Choose)?

People with obesity now have a choice between semaglutide and tirzepatide for weight loss, but deciding which to take is complex.
moreobesity-treatment
#obesity

Weight-loss drug reduces risk of early death for patients with heart failure, trial finds

Tirzepatide reduces the risk of death and worsening heart failure in patients with obesity and preserved heart function.

Weight-loss drugs aren't a magic bullet. Lifestyle changes are key to lasting health

The use of weight-loss medicines like semaglutide and tirzepatide is increasing in popularity due to their success in helping people lose weight.
These medications have been shown to have additional benefits for people with diabetes and cardiovascular disease.

Weight-loss drug reduces risk of early death for patients with heart failure, trial finds

Tirzepatide reduces the risk of death and worsening heart failure in patients with obesity and preserved heart function.

Weight-loss drugs aren't a magic bullet. Lifestyle changes are key to lasting health

The use of weight-loss medicines like semaglutide and tirzepatide is increasing in popularity due to their success in helping people lose weight.
These medications have been shown to have additional benefits for people with diabetes and cardiovascular disease.
moreobesity
#eli-lilly

Taking Mounjaro Reduces Risk of Developing Diabetes by 94 Percent in Three-Year Trial

Lilly's weight loss injectables Zepbound and Mounjaro significantly reduce diabetes risk, showing lasting effects even after treatment ends.

Eli Lilly just halved the price of its weight-loss drug - declaring war on the booming market of knock-offs

Eli Lilly is significantly reducing the price of Zepbound to $399-$549 to combat counterfeits and enhance patient access.

Eli Lilly Blasts Use of Mounjaro and Zepbound for "Cosmetic Weight Loss"

Pharmaceutical company Eli Lilly is warning against off-label use of its weight loss medications.

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Eli Lilly's stock has risen 464.44% since 2020, indicating strong growth potential and key clinical advancements shaping its future.
With a focus on research in oncology and diabetes prevention, Eli Lilly is well-positioned for sustained growth in the coming years.

Taking Mounjaro Reduces Risk of Developing Diabetes by 94 Percent in Three-Year Trial

Lilly's weight loss injectables Zepbound and Mounjaro significantly reduce diabetes risk, showing lasting effects even after treatment ends.

Eli Lilly just halved the price of its weight-loss drug - declaring war on the booming market of knock-offs

Eli Lilly is significantly reducing the price of Zepbound to $399-$549 to combat counterfeits and enhance patient access.

Eli Lilly Blasts Use of Mounjaro and Zepbound for "Cosmetic Weight Loss"

Pharmaceutical company Eli Lilly is warning against off-label use of its weight loss medications.

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Eli Lilly's stock has risen 464.44% since 2020, indicating strong growth potential and key clinical advancements shaping its future.
With a focus on research in oncology and diabetes prevention, Eli Lilly is well-positioned for sustained growth in the coming years.
moreeli-lilly

Shady drugmaker used code words to sell knockoff weight-loss drug: lawsuit

Pivotal Peptides is allegedly operating in a way that poses significant risks to patient safety, utilizing coded language for product orders.
#compounding-pharmacies

Drug makers can't make knockoff weight-loss drugs anymore-and they're mad

Compounding pharmacies are suing the FDA to continue producing tirzepatide imitations despite the drug's supply improving.
The FDA announced that the tirzepatide shortage has been resolved, impacting compounding pharmacies' operations.

The Crackdown on Compounded GLP-1 Meds Has Begun

Eli Lilly is intensifying legal actions against compounded GLP-1 medications amid ongoing product shortages.

Drug makers can't make knockoff weight-loss drugs anymore-and they're mad

Compounding pharmacies are suing the FDA to continue producing tirzepatide imitations despite the drug's supply improving.
The FDA announced that the tirzepatide shortage has been resolved, impacting compounding pharmacies' operations.

The Crackdown on Compounded GLP-1 Meds Has Begun

Eli Lilly is intensifying legal actions against compounded GLP-1 medications amid ongoing product shortages.
morecompounding-pharmacies

The Benefits of Ozempic Are Multiplying

Semaglutide and tirzepatide mimic GLP-1 to control blood sugar levels and induce feelings of fullness, potentially offering benefits for kidney protection and reducing inflammation in conditions like dementia.

Users of New Weight Loss Drug Had Lower Blood Pressure in Study

Tirzepatide, a weight loss drug, was found to significantly lower blood pressures after 36 weeks of use.
The study assessed tirzepatide's effects on weight loss and found that participants taking the drug had lower blood pressures when measured with a 24-hour monitor.
[ Load more ]